Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine vs ondansetron for prevention of nausea and vomiting
IRCT20160825029520N4Phase 3Completed
- Sponsor
- Neyshabour University of Medical Sciences
- Start
- Apr 2023
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atropine and ondansetron in nausea ((none)) and Vomiting (2 arms), sponsored by Neyshabour University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
atropineondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on IRCT20160825029520N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160825029520N4.